FY97 DOT&E Annual Report


ACTD Program
Program cost (FY97) $37.6M
ACTD Manager
Defense Special Weapons Agency (DSWA)
ACTD Sponsor
US European Command


The Counterproliferation ACTD is designed to address the growing need to provide a military capability for precision engagement of weapons of mass destruction (WMD)-related facilities. In order to accomplish this objective, the CP ACTD will develop, integrate, demonstrate and transition to the warfighters, operationally mature technologies that potentially address the unique requirements to enhance the joint counterforce mission to hold WMD-related facilities at risk. The driving CP counterforce requirements include enhancing the ability to predict and control collateral effects and to provide prompt response and reliable kill.

To be effective, an attack on a WMD target facility needs to accomplish two goals: (1) prevent reconstitution of or access to the facility in a timely manner, and (2) contain - or ideally neutralize - the WMD-related materials within the facility. An all-weather, day/night capability and joint operations are key to prompt response. Precision guidance and effective BDA assessment are contributors to reliable kill.

In general, the CP ACTD attempts to (1) integrate weapons, sensors, target planning tools and procedures, and collateral effects algorithms; (2) demonstrate their effectiveness against WMD-related targets; (3) provide residual capabilities and tactical lessons learned to theater and task force commanders. The essential elements of the CP demonstration include:


The CP ACTD is considered a Class III ACTD since it involves a "system of systems" that spans multiple military services and/or mission areas.

The CP ACTD is managed jointly by the Defense Special Weapons Agency (DSWA) as the Demonstration Manager and US European Command (USEUCOM) as the Operations Manager and operational sponsor. Overall guidance for the rationale and conduct of the CP ACTD is provided in the CP ACTD management plan, July 27, 1995.


The CP ACTD conducted four demonstrations in FY97. The first two demonstrations in December 1996 and February 1997, called DIPOLE ORBIT 3 and DIPOLE ORBIT 6 respectively, were each an air strike against a simulated biological weapons storage facility at White Sands Missile Range, New Mexico. Both demonstrations successfully demonstrated the ability of the Integrated Munitions Effects Assessment software tool to predict the collateral effects associated with destroying the targets. The demonstrations also successfully demonstrated the ability of the Hard Target Smart Fuze (HTSF) to control the depth of detonation of the GBU-24 laser-guided bomb.

DIPOLE TIGER 1 and DIPOLE TIGER 2 were demonstrations against two simulated chemical production facilities, also located at White Sands Missile Range. DIPOLE TIGER 1, executed in April 1997, successfully demonstrated the effects of a statically emplaced Tomahawk Land Attack Missile (TLAM) against the target. DIPOLE TIGER 2, executed in May 1997, successfully demonstrated the ability of the HTSF to control the depth of detonation of a GBU-27 laser-guided bomb.


The results of early CP ACTD demonstrations have been positive and show potential. Significant progress has been made in development of both weapons and planning tools. Technical challenges remain in development of critical support systems such as the AUP, TUGS, WBS, TFPM, and ITAG. The major challenge facing the program will be the integration of all these novel elements into a complete, operationally suitable system. The CP program is a well run ACTD that has the potential to provide the warfighter with a system that is both effective and suitable.